✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Mesoblast Limited

Common Name
Mesoblast
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
81
Ticker
MSB
Exchange
Australian Securities Exchange
Description
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory ...

Mesoblast's Board and Committee Meetings Data

Explore Mesoblast's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2026
Board Meeting Count
12a
Board Meeting Attendance Rate
97.92%a
Audit Committee Meeting Count
5a
Audit Committee Meeting Attendance Rate
100%a
Compensation/Remuneration Committee Meeting Count
6a
Compensation/Remuneration Committee Meeting Attendance Rate
100%a
Nomination Committee Meeting Count
6a
Nomination Committee Meeting Attendance Rate
100%a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Mesoblast’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Mesoblast's Annual Report 2026